Eximo Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $60.7M

Eximo General Information

Description

Provider of a hybrid catheter technology designed to offer tissue resection invascular and gastrointestinal endoluminal applications. The company's technology offers optical fibers that deliver short laser pulse and a blunt mechanical knife, enabling doctors to optimize safety and performance during atherectomy procedures to reduce the risk of vessel perforation in patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3 Pekeris street
  • Einstein building Floor Number 1, Tamar Park
  • Rehovot 7670203
  • Israel
Primary Industry
Therapeutic Devices
Acquirer
Vertical(s)
Corporate Office
  • 3 Pekeris street
  • Einstein building Floor Number 1, Tamar Park
  • Rehovot 7670203
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eximo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 02-Oct-2019 $60.7M Completed Generating Revenue
3. Early Stage VC (Series A) 06-Jun-2016 Completed Startup
2. Early Stage VC 16-Aug-2012 $400K $400K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Eximo’s complete valuation and funding history, request access »

Eximo Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of a hybrid catheter technology designed to offer tissue resection invascular and gastrointestinal endoluminal
Therapeutic Devices
Rehovot, Israel

Istanbul, Turkey

Shelton, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eximo Competitors (16)

One of Eximo’s 16 competitors is Alvimedica, a Corporation company based in Istanbul, Turkey.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alvimedica Corporation Istanbul, Turkey
Spine Wave Venture Capital-Backed Shelton, CT
Masimo Formerly PE-Backed Irvine, CA
Cagent Vascular Venture Capital-Backed Wayne, PA
Endologix Corporation Santa Rosa, CA
You’re viewing 5 of 16 competitors. Get the full list »

Eximo Patents

Eximo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12038322-B2 Devices and methods for testing ablation systems Active 21-Jun-2022
US-20230408329-A1 Devices and methods for testing ablation systems Active 21-Jun-2022
US-20240393171-A1 Devices and methods for testing ablation systems Pending 21-Jun-2022
EP-4433111-A1 Smart aspiration system Pending 16-Nov-2021
US-20230149033-A1 Smart aspiration system Pending 16-Nov-2021 A61M1/742
To view Eximo’s complete patent history, request access »

Eximo Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accel Venture Capital Minority
Accelmed Growth/Expansion Minority
Arkin Capital Asset Manager Minority
Incentive Incubator Accelerator/Incubator Minority
Peregrine Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Eximo FAQs

  • When was Eximo founded?

    Eximo was founded in 2012.

  • Where is Eximo headquartered?

    Eximo is headquartered in Rehovot, Israel.

  • What industry is Eximo in?

    Eximo’s primary industry is Therapeutic Devices.

  • Is Eximo a private or public company?

    Eximo is a Private company.

  • What is the current valuation of Eximo?

    The current valuation of Eximo is .

  • What is Eximo’s current revenue?

    The current revenue for Eximo is .

  • How much funding has Eximo raised over time?

    Eximo has raised $2M.

  • Who are Eximo’s investors?

    Accel, Accelmed, Arkin Capital, Incentive Incubator, and Peregrine Ventures are 5 of 8 investors who have invested in Eximo.

  • Who are Eximo’s competitors?

    Alvimedica, Spine Wave, Masimo, Cagent Vascular, and Endologix are some of the 16 competitors of Eximo.

  • When was Eximo acquired?

    Eximo was acquired on 02-Oct-2019.

  • Who acquired Eximo?

    Eximo was acquired by Angiodynamics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process